Jason Napodano, CFA
Research analyst, medium-term horizon, biotech, small-cap

The Neuralstem You Don't Know

This article was co-authored by John Tucker, PhD of Zacks Investment Research, Inc.

Major depressive Disorder (MDD) is characterized by a chronic depressed mood, markedly diminished interest in normally pleasurable activities, unintentional weight changes, insomnia, fatigue, and feelings of worthlessness. The first widely used pharmacological treatment for depression was imipramine, which was discovered by accident during a research program seeking novel sedatives for treating patients with psychosis. Over the next decade a plethora of analogs of imipramine, tricylic antidepressants (TCAs), were synthesized and tested. Although some of these demonstrated a modest reduction in side effects such as sedation and anticholinergic effects, no significant improvement in the modest efficacy of imipramine was achieved (Goodman and Gilman, The Pharmacological Basis of Therapeutics, ...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
FREESA PRO MEMBERS
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details